Thomas Strüngmann (born 1950) founded generic drug maker Hexal AG in 1986.
In 2005, he and his brother Andreas sold Hexal for $6.7B.
They earned $8B on their stake in BioNTech SE, They own approximately 50% of the company as well as significant ownership in 4SC and Immatics
He has a net worth of USD 14.5B making him no. 139th richest person in the world
In 2005, he and his brother Andreas sold Hexal for $6.7B.
They earned $8B on their stake in BioNTech SE, They own approximately 50% of the company as well as significant ownership in 4SC and Immatics
He has a net worth of USD 14.5B making him no. 139th richest person in the world